136 related articles for article (PubMed ID: 3018695)
41. Cyclic AMP-dependent protein kinase in Molt 4b lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI).
O'Dorisio MS; Wood CL; Wenger GD; Vassalo LM
J Immunol; 1985 Jun; 134(6):4078-86. PubMed ID: 2985703
[TBL] [Abstract][Full Text] [Related]
42. Antagonistic analogs of growth hormone releasing hormone (GHRH) inhibit cyclic AMP production of human cancer cell lines in vitro.
Csernus V; Schally AV; Groot K
Peptides; 1999; 20(7):843-50. PubMed ID: 10477085
[TBL] [Abstract][Full Text] [Related]
43. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD
Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448
[TBL] [Abstract][Full Text] [Related]
44. Prolactin-releasing activity of porcine intestinal peptide (PHI-27).
Samson WK; Lumpkin MD; McDonald JK; McCann SM
Peptides; 1983; 4(6):817-9. PubMed ID: 6689504
[TBL] [Abstract][Full Text] [Related]
45. Secretory actions of vasoactive intestinal polypeptide, peptide histidine isoleucine and helodermin in rat small intestine: the effects of putative VIP antagonists upon VIP-induced ion secretion.
Cox HM; Cuthbert AW
Regul Pept; 1989; 26(2):127-35. PubMed ID: 2798955
[TBL] [Abstract][Full Text] [Related]
46. Porcine peptide having N-terminal histidine and C-terminal isoleucine amide (PHI): vasoactive intestinal peptide (VIP) and secretin-like effects in different tissues from the rat.
Bataille D; Gespach C; Laburthe M; Amiranoff B; Tatemoto K; Vauclin N; Mutt V; Rosselin G
FEBS Lett; 1980 Jun; 114(2):240-2. PubMed ID: 6248367
[No Abstract] [Full Text] [Related]
47. Interaction between vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI) in stimulating the secretion of prolactin from rat anterior pituitary cells in vitro.
Inoue T; Kato Y; Koshiyama H; Yanaihara N; Imura H
Neurosci Lett; 1988 Mar; 85(3):363-9. PubMed ID: 3362424
[TBL] [Abstract][Full Text] [Related]
48. Actions of a newly isolated intestinal peptide PHI on pancreatic acini.
Jensen RT; Tatemoto K; Mutt V; Lemp GF; Gardner JD
Am J Physiol; 1981 Dec; 241(6):G498-502. PubMed ID: 6172986
[TBL] [Abstract][Full Text] [Related]
49. Regulation of the concentration of adenosine 3',5'-cyclic monophosphate and the activity of tyrosine hydroxylase in the rat superior cervical ganglion by three neuropeptides of the secretin family.
Ip NY; Baldwin C; Zigmond RE
J Neurosci; 1985 Jul; 5(7):1947-54. PubMed ID: 2862228
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and in vitro bioactivity of C-terminal deleted analogs of human growth hormone-releasing factor.
Ling N; Baird A; Wehrenberg WB; Ueno N; Munegumi T; Brazeau P
Biochem Biophys Res Commun; 1984 Sep; 123(2):854-61. PubMed ID: 6435620
[TBL] [Abstract][Full Text] [Related]
51. Effect of rGRF on exocrine pancreatic secretion of the rat in vivo.
Goffette D; de la Tour J; Chariot J; Roze C
Peptides; 1986; 7 Suppl 1():245-8. PubMed ID: 3092194
[TBL] [Abstract][Full Text] [Related]
52. Comparison of helodermin, VIP and PHI in pancreatic secretion and blood flow in dogs.
Konturek SJ; Yanaihara N; Pawlik W; Jaworek J; Szewczyk K
Regul Pept; 1989 Feb; 24(2):155-66. PubMed ID: 2922493
[TBL] [Abstract][Full Text] [Related]
53. Secretin, VIP, and PHI stimulate rat proximal duodenal surface epithelial bicarbonate secretion in vivo.
Isenberg JI; Wallin B; Johansson C; Smedfors B; Mutt V; Tatemoto K; Emas S
Regul Pept; 1984 Jul; 8(4):315-20. PubMed ID: 6548570
[TBL] [Abstract][Full Text] [Related]
54. Secretin receptors in human pancreatic membranes.
Robberecht P; De Neef P; Waelbroeck M; Camus JC; Scemama JL; Fourmy D; Pradayrol L; Vaysse N; Christophe J
Pancreas; 1988; 3(5):529-35. PubMed ID: 3186683
[TBL] [Abstract][Full Text] [Related]
55. Novel effect of vasoactive intestinal polypeptide and peptide histidine isoleucine: inhibition of in vitro secretion of prolactin in the tilapia, Oreochromis mossambicus.
Kelley KM; Nishioka RS; Bern HA
Gen Comp Endocrinol; 1988 Oct; 72(1):97-106. PubMed ID: 3181742
[TBL] [Abstract][Full Text] [Related]
56. Effects of vasoactive intestinal peptide and its homologues on the substance P-mediated secretion of fluid and protein from the rat submandibular gland.
Iwabuchi Y; Masuhara T
Gen Pharmacol; 1994 Jul; 25(4):705-11. PubMed ID: 7525400
[TBL] [Abstract][Full Text] [Related]
57. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors in chick cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
J Mol Neurosci; 2003 Apr; 20(2):153-62. PubMed ID: 12794309
[TBL] [Abstract][Full Text] [Related]
58. Vasoactive intestinal polypeptide stimulation of cyclic AMP formation in rat central nervous system.
Kaneko T; Nakaya S; Saito S; Yanaihara N; Oka H
Endocrinol Jpn; 1980 Dec; 27 Suppl 1():7-10. PubMed ID: 6112141
[TBL] [Abstract][Full Text] [Related]
59. Acute stimulation of ganglionic tyrosine hydroxylase activity by secretin, VIP and PHI.
Ip NY; Baldwin C; Zigmond RE
Peptides; 1984; 5(2):309-12. PubMed ID: 6147816
[TBL] [Abstract][Full Text] [Related]
60. Receptors for vasoactive intestinal peptide in rat anterior pituitary glands: localization of binding to lactotropes.
Wanke IE; Rorstad OP
Endocrinology; 1990 Apr; 126(4):1981-8. PubMed ID: 2156675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
